Page last updated: 2024-11-04

succinylcholine and Dysthymic Disorder

succinylcholine has been researched along with Dysthymic Disorder in 1 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Dysthymic Disorder: Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. (DSM-IV)

Research Excerpts

ExcerptRelevanceReference
" Comparing the EEG and motor seizure duration in the periods with and without midazolam, no significant differences were recorded, but the dosage of thiopental and of succinylcholine had to be increased markedly after midazolam was discontinued (P < 0."1.30Combining nefazodone and midazolam during ECT. ( al-Dubai, Z; Beraus, W; Conca, A; König, P, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conca, A1
al-Dubai, Z1
König, P1
Beraus, W1

Other Studies

1 other study available for succinylcholine and Dysthymic Disorder

ArticleYear
Combining nefazodone and midazolam during ECT.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Drug Interactions; Dysthymic Di

1999